help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 70, No. 6 1616-1623
doi:10.1210/jcem-70-6-1616
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JØRGENSEN, J. O. L.
Right arrow Articles by CHRISTIANSEN, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JØRGENSEN, J. O. L.
Right arrow Articles by CHRISTIANSEN, J. S.

Pulsatile Versus Continuous Intravenous Administration of Growth Hormone (GH) in GH-Deficient Patients: Effects on Circulating Insulin-Like Growth Factor-I and Metabolic Indices

JENS O. L. JØRGENSEN, NIELS MØLLER, TORSTEN LAURITZEN and JENS S. CHRISTIANSEN

Second University Clinic of Internal Medicine, Aarhus Kommunehospital, and Institute of Experimental Clinical Research, Aarhus University Aarhus, Denmark

Address all correspondence and requests for reprints to: Dr. Jens O. L. Jørgensen, Medical Department M. Aarhus Kommunehospital, DK-8000 C. Aarhus, Denmark.

The episodic and pulsatile nature of GH secretion in normal man is well established. Studies in hypophysectomized rats have indicated that pulsatile administration of GH is superior to continuous infusion in promoting growth, but similar studies have not yet been conducted in human subjects. We compared three different iv GH administration schedules in six GH-deficient patients. They were hospitalized three times for 44 h on three occasions, separated by at least 4 weeks without GH treatment. On each occasion they received 2 IU GH, administered iv as either 1) two boluses (at 2000 and 0200 h), 2) eight boluses (at 3-h intervals starting at 2000 h), or 3) a continuous (2000-0200 h) infusion. Serum insulin-like growth factor-I (IGFI) after eight boluses and that after continuous infusion were almost identical, with a steep increase reaching a peak at 2000–2400 h, followed by a steady decline. The total areas under the curve, expressed as mean levels (micrograms per L), were 147.6 ± 11.8 (eight boluses) and 151.2 ± 8.9 (infusion; P = NS). The change with time in IGF-I after the two-bolus regimen differed significantly from that in the other studies (P < 0.001), displaying only a modest increase, as also reflected in a smaller area under the curve of serum IGF-I (125.3 ± 8.7 µg/L; P < 0.05). No differences in blood glucose, serum insulin, or plasma glucagon were observed when comparing the three studies. Both blood glucose and serum insulin tended to be elevated during the second night of each study. Almost identical fluctuations were recorded in lipid intermediates in the three studies, with nightly elevations being more pronounced on the first night. Alanine and lactate exhibited nearly identical patterns in the three studies and were characterized by low nocturnal levels. These data indicate that small but frequent iv boluses and continuous infusion of GH are equally effective in generating an increase in IGF-I in GH-deficient patients, whereas the same amount of GH given as two large boluses results in a significantly smaller increase in IGF-I. This could mean that a prolongation of the period during which serum GH is above zero in GH-treated subjects is just as essential as pulsatility for the growth-promoting effects of the hormone.

Received October 10, 1989.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. Surya, J. F. Horowitz, N. Goldenberg, A. Sakharova, M. Harber, A. S. Cornford, K. Symons, and A. L. Barkan
The Pattern of Growth Hormone Delivery to Peripheral Tissues Determines Insulin-Like Growth Factor-1 and Lipolytic Responses in Obese Subjects
J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2828 - 2834.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Sherlock, E. Fernandez-Rodriguez, A. A. Alonso, R. C. Reulen, J. Ayuk, R. N. Clayton, G. Holder, M. C. Sheppard, A. Bates, and P. M. Stewart
Medical Therapy in Patients with Acromegaly: Predictors of Response and Comparison of Efficacy of Dopamine Agonists and Somatostatin Analogues
J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1255 - 1263.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. D. Veldhuis, D. M. Keenan, and S. M. Pincus
Motivations and Methods for Analyzing Pulsatile Hormone Secretion
Endocr. Rev., December 1, 2008; 29(7): 823 - 864.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. P. Tuckow, K. R. Rarick, W. J. Kraemer, J. O. Marx, W. C. Hymer, and B. C. Nindl
Nocturnal growth hormone secretory dynamics are altered after resistance exercise: deconvolution analysis of 12-hour immunofunctional and immunoreactive isoforms
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1749 - R1755.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Yonezawa, K. Mogi, J. Y. Li, R. Sako, K. Yamanouchi, and M. Nishihara
Modulation of Growth Hormone Pulsatility by Sex Steroids in Female Goats
Endocrinology, June 1, 2005; 146(6): 2736 - 2743.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Endocr. Rev., February 1, 2005; 26(1): 114 - 146.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. S. Farhy and J. D. Veldhuis
Putative GH pulse renewal: periventricular somatostatinergic control of an arcuate-nuclear somatostatin and GH-releasing hormone oscillator
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1030 - R1042.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. R. Biermasz, A. M. Pereira, M. Frolich, J. A. Romijn, J. D. Veldhuis, and F. Roelfsema
Octreotide represses secretory-burst mass and nonpulsatile secretion but does not restore event frequency or orderly GH secretion in acromegaly
Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E25 - E30.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. A. Jaffe, D. K. Turgeon, K. Lown, R. Demott-Friberg, and P. B. Watkins
Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans
Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1008 - E1015.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. M. Cook, B. M. K. Biller, M. L. Vance, A. R. Hoffman, L. S. Phillips, K. M. Ford, D. P. Benziger, A. Illeperuma, S. L. Blethen, K. M. Attie, et al.
The Pharmacokinetic and Pharmacodynamic Characteristics of a Long-Acting Growth Hormone (GH) Preparation (Nutropin Depot) in GH-Deficient Adults
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4508 - 4514.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Laursen, C. H. Gravholt, L. Heickendorff, J. Drustrup, A.-M. Kappelgaard, J. O. L. Jørgensen, and J. S. Christiansen
Long-Term Effects of Continuous Subcutaneous Infusion Versus Daily Subcutaneous Injections of Growth Hormone (GH) on the Insulin-Like Growth Factor System, Insulin Sensitivity, Body Composition, and Bone and Lipoprotein Metabolism in GH-Deficient Adults
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1222 - 1228.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. R. Peacey, A. A. Toogood, J. D. Veldhuis, M. O. Thorner, and S. M. Shalet
The Relationship between 24-Hour Growth Hormone Secretion and Insulin-Like Growth Factor I in Patients with Successfully Treated Acromegaly: Impact of Surgery or Radiotherapy
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 259 - 266.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Laursen, A. Flyvbjerg, J. O. L. Jørgensen, R. C. Baxter, and J. S. Christiansen
Stimulation of the 150-Kilodalton Insulin-Like Growth Factor-Binding Protein-3 Ternary Complex by Continuous and Pulsatile Patterns of Growth Hormone (GH) Administration in GH-Deficient Patients
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4310 - 4314.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. M. Keenan and J. D. Veldhuis
Explicating hypergonadotropism in postmenopausal women: a statistical model
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2000; 278(5): R1247 - R1257.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. E. Muller, V. Locatelli, and D. Cocchi
Neuroendocrine Control of Growth Hormone Secretion
Physiol Rev, April 1, 1999; 79(2): 511 - 607.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. M. Chapman, M. L. Hartman, K. S. Pieper, E. H. Skiles, S. S. Pezzoli, R. L. Hintz, and M. O. Thorner
Recovery of Growth Hormone Release from Suppression by Exogenous Insulin-Like Growth Factor I (IGF-I): Evidence for a Suppressive Action of Free Rather Than Bound IGF-I
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2836 - 2842.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
H. J. Lee, G. Riley, O. Johnson, J. L. Cleland, N. Kim, M. Charnis, L. Bailey, E. Duenas, A. Shahzamani, M. Marian, et al.

J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1431 - 1439.
[Abstract]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Van den Berghe, F. de Zegher, J. D. Veldhuis, P. Wouters, M. Awouters, W. Verbruggen, M. Schetz, C. Verwaest, P. Lauwers, R. Bouillon, et al.
The Somatotropic Axis in Critical Illness: Effect of Continuous Growth Hormone (GH)-Releasing Hormone and GH-Releasing Peptide-2 Infusion
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 590 - 599.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society